N
EHC icon

Natixis’s Encompass Health EHC Stock Holding History

Natixis’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.19M Buy
90,958
+7,131
+9% +$739K 0.04% 316
2026
Q1 		$8.11M Sell
83,827
-39,500
-32% -$4.05M 0.03% 337
2025
Q4 		$13.1M Buy
+123,327
New +$14.3M 0.05% 289
2025
Q3 		– Sell
-3,294
Closed -$404K – 1109
2025
Q2 		$404K Sell
3,294
-681
-17% -$77.8K ﹤0.01% 729
2025
Q1 		$400K Sell
3,975
-803
-17% -$78.4K ﹤0.01% 684
2024
Q4 		$441K Buy
+4,778
New +$469K ﹤0.01% 729
2024
Q3 		– Sell
-239
Closed -$20.5K – 1002
2024
Q2 		$20.5K Sell
239
-616
-72% -$51.7K ﹤0.01% 818
2024
Q1 		$70.6K Buy
855
+530
+163% +$38.8K ﹤0.01% 804
2023
Q4 		$21.7K Buy
+325
New +$21.1K ﹤0.01% 876
2023
Q2 		– Sell
-669
Closed -$36.2K – 1055
2023
Q1 		$36.2K Buy
+669
New +$38.9K ﹤0.01% 848
2019
Q3 		– Sell
-81,264
Closed -$4.1M – 835
2019
Q2 		$4.1M Sell
81,264
-236,899
-74% -$11.5M 0.03% 361
2019
Q1 		$14.8M Buy
318,163
+276,416
+662% +$14M 0.09% 210
2018
Q4 		$2.05M Buy
41,747
+36,718
+730% +$2.09M 0.02% 419
2018
Q3 		$312K Sell
5,029
-6,280
-56% -$382K ﹤0.01% 680
2018
Q2 		$609K Sell
11,309
-3,723
-25% -$186K ﹤0.01% 669
2018
Q1 		$684K Buy
+15,032
New +$644K ﹤0.01% 636
2017
Q4 		– Sell
-28,293
Closed -$1.04M – 925
2017
Q3 		$1.04M Buy
28,293
+16,163
+133% +$576K 0.01% 512
2017
Q2 		$467K Sell
12,130
-3,031
-20% -$111K 0.01% 538
2017
Q1 		$516K Buy
15,161
+5,661
+60% +$186K 0.01% 505
2016
Q4 		$312K Buy
+9,500
New +$308K ﹤0.01% 621

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Natixis's EHC Position: Q2 2026 in Review

Natixis increased its Encompass Health (EHC) stake by 8.5% in Q2 2026, buying an estimated $739K and bringing the position to 90,958 shares worth $9.19M. The position accounts for 0.04% of the portfolio, ranked #316.

Natixis first reported a position in EHC in Q4 2016 and has held it in 20 quarters since. The position peaked at $14.8M in Q1 2019. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Natixis held 90,958 shares of Encompass Health worth $9.19M as of Q2 2026.
  • Natixis bought 7,131 Encompass Health shares in Q2 2026, an estimated $739K.
  • Encompass Health made up 0.04% of Natixis's portfolio in Q2 2026, its #316 holding.
  • Natixis first reported a position in Encompass Health in Q4 2016 and has held it in 20 quarters since.
  • Natixis's Encompass Health position peaked at $14.8M in Q1 2019.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.